Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fcaffc23e84e1a7269de0d17be11b37 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
filingDate |
1977-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1978-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9b60620f9215c4dce0eef5ead79f5db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a2a29689a10902613bcf8e659bbf2c9 |
publicationDate |
1978-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4105794-A |
titleOfInvention |
Process of mitigating cholelithiasis |
abstract |
Therapeutic composition useful for mitigating cholelithiasis in humans comprising 3-hydroxy-3-methylglutaric acid, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable non-toxic carrier. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5320601-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4264583-A |
priorityDate |
1977-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |